<http://schema.org/description>
"Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel) works. Tafamidis, approved for use in Europe and currently under review by the US Food and Drug Administration (FDA), is the first medication approved by a major regulatory agency to treat an amyloid disease, a class of conditions that include Alzheimer's."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2012-05-reveals-world-drug-amyloid-disease.html>